Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kamolika Roy

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
The Psychiatric Clinics of North America|November 17, 2022
COVID-19: Brain EffectsEbony Dix, Kamolika Roy
Human Gene Therapy|April 14, 2010
Ocular gene therapy: an evaluation of recombinant adeno-associated virus-mediated gene therapy interventions for the treatment of ocular diseaseKamolika Roy, Linda Stein, Shalesh Kaushal
Expert Opinion on Biological Therapy|February 9, 2011
Clinical gene therapy for the treatment of RPE65-associated Leber congenital amaurosisLinda Stein, Kamolika Roy, Lei Lei, et al.
Neural Regeneration Research|September 3, 2015
Glycogen and amyloid-beta: key players in the shift from neuronal hyperactivity to hypoactivity observed in Alzheimer's disease?Britanny Bass, Sarah Upson, Kamolika Roy, et al.
The Clinical Neuropsychologist|May 13, 2014
Development of a psychometrically equivalent short form of the Face-Name Associative Memory Exam for use along the early Alzheimer's disease trajectoryKathryn V Papp, Rebecca E Amariglio, Maria Dekhtyar, et al.
Journal of Alzheimer'S Disease : JAD|June 6, 2014
Regional fluorodeoxyglucose metabolism and instrumental activities of daily living across the Alzheimer's disease spectrumKamolika Roy, Lesley C Pepin, Marlie Philiossaint, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
The Psychiatric Clinics of North America|November 17, 2022
COVID-19: Brain EffectsEbony Dix, Kamolika Roy
Human Gene Therapy|April 14, 2010
Ocular gene therapy: an evaluation of recombinant adeno-associated virus-mediated gene therapy interventions for the treatment of ocular diseaseKamolika Roy, Linda Stein, Shalesh Kaushal
Expert Opinion on Biological Therapy|February 9, 2011
Clinical gene therapy for the treatment of RPE65-associated Leber congenital amaurosisLinda Stein, Kamolika Roy, Lei Lei, et al.
Neural Regeneration Research|September 3, 2015
Glycogen and amyloid-beta: key players in the shift from neuronal hyperactivity to hypoactivity observed in Alzheimer's disease?Britanny Bass, Sarah Upson, Kamolika Roy, et al.
The Clinical Neuropsychologist|May 13, 2014
Development of a psychometrically equivalent short form of the Face-Name Associative Memory Exam for use along the early Alzheimer's disease trajectoryKathryn V Papp, Rebecca E Amariglio, Maria Dekhtyar, et al.
Journal of Alzheimer'S Disease : JAD|June 6, 2014
Regional fluorodeoxyglucose metabolism and instrumental activities of daily living across the Alzheimer's disease spectrumKamolika Roy, Lesley C Pepin, Marlie Philiossaint, et al.
Pageof 1